PSCNX Mutual Fund

PSCNX Mutual Fund

NAV$18.91
See how much of PSCNX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Jul 31, 2026

Net Assets
$88M
Expense Ratio
1.09%
Dividend Yield (Current)
-
Holdings
87
Inception Date
Dec 17, 2015
Fund Family
PENN Capital Funds
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO

Performance

YTD+11.88%
1 Year+11.00%
3 Year+15.25%
5 Year+6.47%
10 Year+12.24%

Asset Allocation

Stocks: 98.59%
Bonds: 1.40%
See how much of PSCNX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
LGNDLigand Pharmaceuticals, Inc.2.25%
MIRMMirum Pharmaceuticals, Inc.2.11%
KNSA:LNKiniksa Pharmaceuticals, Ltd.2.08%
TGTXTg Therapeutics Inc Common Stock1.96%
FBKFb Financial Corp1.83%
Top 10 Concentration: 18.81%Report Date: Jul 31, 2026
Download all 87 holdings for PSCNX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Latest Distribution
$3.81
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

PSCNX Mutual Fund Overview

PSCNX Mutual Fund (Penn Capital Special Situations Small Cap Equity Fund Institutional Class) is managed by PENN Capital Funds with $87.5M in net assets. PSCNX expense ratio is 1.09%, holding 87 positions across sectors including Consumer Discretionary, Industrials, Financials. Inception date: 2015-12-17.

PSCNX performance shows a YTD return of 11.88%. The 1-year return is 11.00% and the 5-year return is 6.47%.

PSCNX top holdings include Ligand Pharmaceuticals, Inc. (2.3%), Mirum Pharmaceuticals, Inc. (2.1%), Kiniksa Pharmaceuticals, Ltd. (2.1%), Tg Therapeutics Inc Common Stock (2.0%), Fb Financial Corp (1.8%). Go to all PSCNX holdings, PSCNX sectors, or PSCNX dividends.

PSCNX can be compared against other funds. Use PSCNX overlap to find shared positions, or PSCNX vs another fund for a side-by-side view. PSCNX alternatives are available via the screener, along with tax-loss harvesting opportunities.